{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:11:42Z","timestamp":1794705102513,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2019JJ30042"],"award-info":[{"award-number":["2019JJ30042"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012486","name":"Innovation-Driven Project of Central South University","doi-asserted-by":"publisher","award":["2020CX047"],"award-info":[{"award-number":["2020CX047"]}],"id":[{"id":"10.13039\/501100012486","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for Central Universities of the Southwest University","award":["5330500110"],"award-info":[{"award-number":["5330500110"]}]},{"name":"Science and Technology Innovation Program of Hunan Province","award":["2021RC3030"],"award-info":[{"award-number":["2021RC3030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite novel advances in screening, targeting and immunotherapies, early diagnosis and satisfactory treatments against hepatocellular carcinoma (HCC) remain formidable challenges. Given the unique advantages, carbon quantum dots (CQDs) become a smart theranostic nanomaterial for cancer diagnosis and therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this work, a type of bio-friendly CQDs, trichrome-tryptophan-sorbitol CQDs (TC-WS-CQDs), is synthesized from natural biocompatible tryptophan via the one-pot hydrothermal method. Compared with normal hepatocytes, a much stronger green fluorescence is detected in HCC cells, indicating the ability of TC-WS-CQDs to target HCC cells. Furthermore, green-emitting TC-WS-CQDs generate large amounts of reactive oxygen species (ROS), leading to autophagy of HCC cells. Additionally, the green-emitting TC-WS-CQDs perform significant tumor inhibition by inducing autophagy via p53-AMPK pathway in vitro and in vivo studies with almost no systemic toxicity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results may highlight a promising anticancer nanotheranostic strategy with integration of diagnosis, targeting, and therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-022-01275-2","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T10:02:58Z","timestamp":1644832978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Tryptophan-sorbitol based carbon quantum dots for theranostics against hepatocellular carcinoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiekang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-348X","authenticated-orcid":false,"given":"Xuegong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"1275_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209.","journal-title":"CA Cancer J Clin"},{"key":"1275_CR2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.31139","volume":"72","author":"G Fern\u00e1ndez Varo","year":"2020","unstructured":"Fern\u00e1ndez Varo G, Perram\u00f3n M, Carvajal S, Or\u00f3 D, Casals E, Boix L, Oller L, Mac\u00edas Mu\u00f1oz L, Marf\u00e0 S, Casals G, Morales Ruiz M, Casado P, Cutillas PR, Bruix J, Navasa M, Fuster J, Garcia Valdecasas JC, Pavel MC, Puntes V, Jim\u00e9nez W. Bespoken nanoceria: an effective treatment in experimental hepatocellular carcinoma. Hepatology. 2020;72:1267.","journal-title":"Hepatology"},{"key":"1275_CR3","doi-asserted-by":"publisher","first-page":"1905233","DOI":"10.1002\/smll.201905233","volume":"16","author":"Z Ren","year":"2019","unstructured":"Ren Z, Chen X, Hong L, Zhao X, Cui G, Li A, Liu Y, Zhou L, Sun R, Shen S, Li J, Lou J, Zhou H, Wang J, Xu G, Yu Z, Song Y, Chen X. Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small. 2019;16:1905233.","journal-title":"Small"},{"key":"1275_CR4","doi-asserted-by":"publisher","first-page":"m3544","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371:m3544.","journal-title":"BMJ"},{"key":"1275_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301.","journal-title":"Lancet"},{"key":"1275_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhep.2019.09.025","volume":"72","author":"A Cheng","year":"2020","unstructured":"Cheng A, Hsu C, Chan SL, Choo S, Kudo M. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2020;72:307.","journal-title":"J Hepatol"},{"key":"1275_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jconrel.2014.04.027","volume":"190","author":"JH Ryu","year":"2014","unstructured":"Ryu JH, Lee S, Son S, Kim SH, Leary JF, Choi K, Kwon IC. Theranostic nanoparticles for future personalized medicine. J Control Release. 2014;190:477.","journal-title":"J Control Release"},{"key":"1275_CR8","doi-asserted-by":"publisher","first-page":"1606857","DOI":"10.1002\/adma.201606857","volume":"29","author":"X Li","year":"2017","unstructured":"Li X, Kim J, Yoon J, Chen X. Cancer-associated, stimuli-driven, turn on theranostics for multimodality imaging and therapy. Adv Mater. 2017;29:1606857.","journal-title":"Adv Mater"},{"key":"1275_CR9","doi-asserted-by":"publisher","first-page":"1805087","DOI":"10.1002\/smll.201805087","volume":"15","author":"J Du","year":"2019","unstructured":"Du J, Xu N, Fan J, Sun W, Peng X. Carbon dots for in vivo bioimaging and theranostics. Small. 2019;15:1805087.","journal-title":"Small"},{"key":"1275_CR10","doi-asserted-by":"publisher","first-page":"1603524","DOI":"10.1002\/adfm.201603524","volume":"27","author":"H Huang","year":"2017","unstructured":"Huang H, Lovell JF. Advanced functional nanomaterials for theranostics. Adv Funct Mater. 2017;27:1603524.","journal-title":"Adv Funct Mater"},{"key":"1275_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.talanta.2016.11.030","volume":"166","author":"HN Abdelhamid","year":"2017","unstructured":"Abdelhamid HN, Talib A, Wu HF. One pot synthesis of gold - carbon dots nanocomposite and its application for cytosensing of metals for cancer cells. Talanta. 2017;166:357.","journal-title":"Talanta"},{"key":"1275_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12951-020-00672-9","volume":"18","author":"Y Wu","year":"2020","unstructured":"Wu Y, Deng P, Tian Y, Feng J, Xiao J, Li J, Liu J, Li G, He Q. Simultaneous and sensitive determination of ascorbic acid, dopamine and uric acid via an electrochemical sensor based on PVP-graphene composite. J Nanobiotechnol. 2020;18:112.","journal-title":"J Nanobiotechnol"},{"key":"1275_CR13","doi-asserted-by":"publisher","first-page":"B1552","DOI":"10.1149\/2.1071915jes","volume":"166","author":"G Li","year":"2019","unstructured":"Li G, Zhong P, Ye Y, Wan X, Cai Z, Yang S, Xia Y, Li Q, Liu J, He Q. A highly sensitive and stable dopamine sensor using shuttle-like \u03b1-Fe2O3 nanoparticles\/electro-reduced graphene oxide composites. J Electrochem Soc. 2019;166:B1552.","journal-title":"J Electrochem Soc"},{"key":"1275_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/21691401.2017.1374282","volume":"46","author":"A Usmani","year":"2018","unstructured":"Usmani A, Mishra A, Ahmad M. Nanomedicines: a theranostic approach for hepatocellular carcinoma. Artif Cells Nanomed Biotechnol. 2018;46:680.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1275_CR15","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.7150\/thno.27631","volume":"8","author":"Q Xu","year":"2018","unstructured":"Xu Q, Wan J, Bie N, Song X, Yang X, Yong T, Zhao Y, Yang X, Gan L. A biomimetic gold nanocages-based nanoplatform for efficient tumor ablation and reduced inflammation. Theranostics. 2018;8:5362.","journal-title":"Theranostics"},{"key":"1275_CR16","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1021\/acs.nanolett.7b00132","volume":"17","author":"J Shen","year":"2017","unstructured":"Shen J, Kim H, Wolfram J, Mu C, Zhang W, Liu H, Xie Y, Mai J, Zhang H, Li Z, Guevara M, Mao Z, Shen H. A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer. Nano Lett. 2017;17:2913.","journal-title":"Nano Lett"},{"key":"1275_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.addr.2018.08.010","volume":"138","author":"D Ji","year":"2019","unstructured":"Ji D, M\u00e9nard-Moyon C, Bianco A. Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics. Adv Drug Deliv Rev. 2019;138:211.","journal-title":"Adv Drug Deliv Rev"},{"key":"1275_CR18","doi-asserted-by":"publisher","first-page":"9777","DOI":"10.1039\/D0TB01826K","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Shi N, Zhang W, Zhang H, Song Y, Zhu W, Feng X. Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis. J Mater Chem B. 2020;8:9777.","journal-title":"J Mater Chem B"},{"key":"1275_CR19","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1002\/adma.201500323","volume":"27","author":"J Ge","year":"2015","unstructured":"Ge J, Jia Q, Liu W, Guo L, Liu Q, Lan M, Zhang H, Meng X, Wang P. Red-emissive carbon dots for fluorescent, photoacoustic, and thermal theranostics in living mice. Adv Mater. 2015;27:4169.","journal-title":"Adv Mater"},{"key":"1275_CR20","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.1002\/adma.201202599","volume":"24","author":"B Kong","year":"2012","unstructured":"Kong B, Zhu A, Ding C, Zhao X, Li B, Tian Y. Carbon dot-based inorganic-organic nanosystem for two-photon imaging and biosensing of pH variation in living cells and tissues. Adv Mater. 2012;24:5844.","journal-title":"Adv Mater"},{"key":"1275_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/bios10060068","volume":"10","author":"M Zulfajri","year":"2020","unstructured":"Zulfajri M, Abdelhamid HN, Sudewi S, Dayalan S, Rasool A, Habib A, Huang GG. Plant part-derived carbon dots for biosensing. Biosensors. 2020;10:68.","journal-title":"Biosensors"},{"key":"1275_CR22","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1021\/acsnano.5b05575","volume":"9","author":"M Zheng","year":"2015","unstructured":"Zheng M, Ruan S, Liu S, Sun T, Qu D, Zhao H, Xie Z, Gao H, Jing X, Sun Z. Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells. ACS Nano. 2015;9:11455.","journal-title":"ACS Nano"},{"key":"1275_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41551-020-0540-y","volume":"4","author":"S Li","year":"2020","unstructured":"Li S, Su W, Wu H, Yuan T, Yuan C, Liu J, Deng G, Gao X, Chen Z, Bao Y, Yuan F, Zhou S, Tan H, Li Y, Li X, Fan L, Zhu J, Chen AT, Liu F, Zhou Y. Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids. Nat Biomed Eng. 2020;4:704.","journal-title":"Nat Biomed Eng"},{"key":"1275_CR24","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/cancers13091991","volume":"13","author":"G Nocito","year":"2021","unstructured":"Nocito G, Calabrese G, Forte S, Petralia S, Puglisi C, Campolo M, Esposito E, Conoci S. Carbon dots as promising tools for cancer diagnosis and therapy. Cancers. 2021;13:1991.","journal-title":"Cancers"},{"key":"1275_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-021-21080-z","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yu N, Fang W, Tan Q, Ji R, Yang L, Wei S, Zhang X, Miao A. Photodegradation of carbon dots cause cytotoxicity. Nat Commun. 2021;12:812.","journal-title":"Nat Commun"},{"key":"1275_CR26","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1039\/C8CS00445E","volume":"48","author":"K Nekoueian","year":"2019","unstructured":"Nekoueian K, Amiri M, Sillanpaa M, Marken F, Boukherroub R, Szunerits S. Carbon-based quantum particles: an electroanalytical and biomedical perspective. Chem Soc Rev. 2019;48:4281.","journal-title":"Chem Soc Rev"},{"key":"1275_CR27","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.7150\/thno.40414","volume":"10","author":"L Guo","year":"2020","unstructured":"Guo L, He N, Zhao Y, Liu T, Deng Y. Autophagy modulated by inorganic nanomaterials. Theranostics. 2020;10:3206.","journal-title":"Theranostics"},{"key":"1275_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J, de Oliveira AC, Santoro A, Raoul J, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz J, Borbath I, H\u00e4ussinger D, Giannaris T. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378.","journal-title":"N Engl J Med"},{"key":"1275_CR29","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han K, Ikeda K, Piscaglia F, Baron A, Park J, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163.","journal-title":"Lancet"},{"key":"1275_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"A Cheng","year":"2009","unstructured":"Cheng A, Kang Y, Chen Z, Tsao C, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang T, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25.","journal-title":"Lancet Oncol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01275-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T10:11:15Z","timestamp":1644833475000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01275-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01275-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were approved by the Ethical Committee of Xiangya Hospital, Central South University in compliance with the law on experimental animals and the Ethical approval number is 201603112.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}